Literature DB >> 14288547

MANNITOL THERAPY IN ACUTE RENAL FAILURE.

R G LUKE, A L LINTON, J D BRIGGS, A C KENNEDY.   

Abstract

Entities:  

Keywords:  ANURIA; BLOOD CHEMICAL ANALYSIS; DIURETICS; EXCRETION; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; MANNITOL; POSTOPERATIVE COMPLICATIONS; UREA; URINE; WOUNDS AND INJURIES

Mesh：

Substances：

Year:  1965        PMID： 14288547     DOI： 10.1016/s0140-6736(65)91216-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Prevention and early management of acute renal failure.

Authors:  R G Luke; A C Kennedy
Journal:  Postgrad Med J       Date:  1967-04       Impact factor: 2.401

Review 2.  Acute renal failure.

Authors:  A L Linton
Journal:  Can Med Assoc J       Date:  1974-04-20       Impact factor: 8.262

3.  Diagnostic differentiation between advanced functional and acute organic renal failure.

Authors:  P P Figdor; G Höltl; B Zinnbauer
Journal:  Int Urol Nephrol       Date:  1972       Impact factor: 2.370

4.  Changes in renal function associated with operations.

Authors:  P P Figdor; G Höltl; F Zekert; B Zinnbauer
Journal:  Int Urol Nephrol       Date:  1972       Impact factor: 2.370

5.  Acute renal failure and the anaesthetist.

Authors:  A C Kennedy
Journal:  Proc R Soc Med       Date:  1968-11

Review 6.  Acute renal failure in the intensive care unit. Part 2.

Authors:  H L Corwin; J V Bonventre
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

7.  Acute renal failure and open heart surgery.

Authors:  E D Yeboah; A Petrie; J L Pead
Journal:  Br Med J       Date:  1972-02-12

8.  Diagnostic indices in acute renal failure.

Authors:  S P Handa; P A Morrin
Journal:  Can Med Assoc J       Date:  1967-01-14       Impact factor: 8.262

Review 9.  Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.

Authors:  Ana L Huerta-Alardín; Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2004-10-20       Impact factor: 9.097
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.